Our Cytochrome P450 (CYP) inhibition assay (IC50) services help to understand the properties of a New Chemical Entity's (NCE) drug-drug reaction. CYP P450 assay also aims to understand the drug's enzymatic conversion into one or more than one metabolite. The understanding of the metabolic pathway of the drug helps to assess the nature of the drug. CYP P450 inhibition data help medicinal chemists to enhance the properties of the drug and design strategies to investigate clinical DDI studies.
Aurigene Pharmaceutical Services is
that provides contract research and manufacturing services
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.